CD4 and neoplasm: Tumor-derived ExVs were able to increase the activation of caspase-3, caspase-7 and caspase-9 and down-regulate the anti-apoptotic proteins, including BCL-2, MCL-1 and BCL-xL, in CD4+T cells.